These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 27100301)
1. Chemotherapy in elderly patients with nonsmall cell lung cancer. Veluswamy RR; Levy B; Wisnivesky JP Curr Opin Pulm Med; 2016 Jul; 22(4):336-43. PubMed ID: 27100301 [TBL] [Abstract][Full Text] [Related]
2. Lung cancer in the elderly. Gridelli C; Langer C; Maione P; Rossi A; Schild SE J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989 [TBL] [Abstract][Full Text] [Related]
3. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents. Meoni G; Cecere FL; Lucherini E; Di Costanzo F J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465 [TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872 [TBL] [Abstract][Full Text] [Related]
5. Treatment of locally advanced non-small cell lung cancer in the elderly. Gridelli C; Maione P; Rossi A; Ciardiello F; Raben D Curr Opin Oncol; 2005 Mar; 17(2):130-4. PubMed ID: 15725917 [TBL] [Abstract][Full Text] [Related]
6. Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer. Weinmann M; Jeremic B; Toomes H; Friedel G; Bamberg M Lung Cancer; 2003 Mar; 39(3):233-53. PubMed ID: 12609562 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada. Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258 [TBL] [Abstract][Full Text] [Related]
9. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer. Aggarwal C; Langer CJ Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616 [TBL] [Abstract][Full Text] [Related]
10. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy. Socinski MA Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology. Gridelli C; Balducci L; Ciardiello F; Di Maio M; Felip E; Langer C; Lilenbaum RC; Perrone F; Senan S; de Marinis F Clin Lung Cancer; 2015 Sep; 16(5):325-33. PubMed ID: 25862554 [TBL] [Abstract][Full Text] [Related]
12. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group. Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833 [TBL] [Abstract][Full Text] [Related]
13. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Belani CP; Fossella F Cancer; 2005 Dec; 104(12):2766-74. PubMed ID: 16288485 [TBL] [Abstract][Full Text] [Related]
14. Advanced non-small-cell lung cancer in the elderly. Vamvakas L; Saloustros E; Karampeazis A; Georgoulias V Clin Lung Cancer; 2009 May; 10(3):158-67. PubMed ID: 19443335 [TBL] [Abstract][Full Text] [Related]
15. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G; Rusthoven J; Newman T; Findlay B; Evans W Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750 [TBL] [Abstract][Full Text] [Related]
16. Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity. Almodovar T; Teixeira E; Barroso A; Soares M; Queiroga HJ; Cavaco-Silva J; Barata F Pulmonology; 2019; 25(1):40-50. PubMed ID: 30266308 [TBL] [Abstract][Full Text] [Related]
17. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for treatment of lung cancer in the elderly. van Veggel BA; Biesma B; Smit EF Expert Opin Pharmacother; 2015 May; 16(7):1021-34. PubMed ID: 25797389 [TBL] [Abstract][Full Text] [Related]
19. A review of the management of elderly patients with non-small-cell lung cancer. Blanco R; Maestu I; de la Torre MG; Cassinello A; Nuñez I Ann Oncol; 2015 Mar; 26(3):451-63. PubMed ID: 25060421 [TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced lung cancer in the elderly. Gajra A; Lichtman SM Hosp Pract (1995); 2011 Apr; 39(2):107-15. PubMed ID: 21576903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]